How often do you see this with a new drug/treatment.
I think they have found their initial niche. If you work in the medical profession in this particular area, this has to be a no brainer as a treatment. Aus market asleep at the wheel once again.
Ann: Patient Dosing Complete in Phase II ABSSSI Trial of R327G, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.020(5.97%) |
Mkt cap ! $104.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $60.06K | 172.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23561 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 15844 | 2 |
View Market Depth
| Last trade - 12.10pm 22/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |